Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study

References

• Adewuya AO, Ola BA, Mosaku SK, Fatoye FO, Eegunranti AB. 2006. Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria. Acta Psychiatr Scand 113:207–211.
   PubMed Web of Science ®Google Scholar
• Allain H, Bentué-Ferrer D, Breton S, Polard E, Gandon JM. 2003. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg. Hum Psychopharmacol 18:369–374.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 1994. DSM-IV. Diagnostic and statistical manual of mental disorders. 4th. Washington, DC: American Psychiatric Association.
   Google Scholar
• American Psychiatric Association. 2000. DSM-IV-TR. Diagnostic and statistical manual of mental disorders. 4th. A text revision, Washington, DC: American Psychiatric Association.
   Google Scholar
• Bergstrom RF, Mitchell M, Witcher J, Houston, J, Hill A, Taylor C, . 2004. Rapid onset of absorption with olanzapine orally disintegrating tablets. J Emerg Nurs 30(5):416–417.
   Google Scholar
• Bitter I, Treuer T, Dyachkova Y, Martenyi F, McBride MS, Ungvari GS. 2008. Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Neuropsychopharmacol 18:170–180.
   PubMedGoogle Scholar
• Bobon D, Woggon B, Association for Methodology and Documentation in Psychiatry. 1986. The AMDP-system in clinical psychopharmacology. Br J Psychiatry 148:467–468.
   PubMed Web of Science ®Google Scholar
• Chilvers C, Dewey M, Fielding K, Gretton V, Miller P, Palmer B, . 2001. Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. Br Med J 322:772–775.
   PubMed Web of Science ®Google Scholar
• Czekalla J, Wagner T, Schacht A, Kluge M, Kinon B. 2007. Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients. Patient Prefer Adherence 1:19–27.
   PubMedGoogle Scholar
• Dardennes R, Chartier F, Heurtebize N, Olivier V, Perrin E. 2004. Naturalistic use of the orally disintegrating tablet formulation of olanzapine in acute schizophrenic patients: An observational prospective study. Int J Neuropsychopharmacol 7(Suppl. 2):P01.389.
   Google Scholar
• Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, . 2005. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 62:717–724.
   PubMed Web of Science ®Google Scholar
• Dilbaz N, Karamustafalioglu O, Oral T, Önder E, Cetin M. 2006. Evaluation of compliance to treatment and factors affecting compliance for schizophrenia outpatients (in Turkish). Bull Clin Psychopharmacol 16:223–232.
   Google Scholar
• Dossenbach M, Pecenak J, Szulc A, Irimia V, Anders M, Logozar-Perkovic D, . 2008. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. J Clin Psychiatry 69:1901–1915.
   PubMedGoogle Scholar
• Dowson AJ, Almqvist P. 2005. The convenience of, and patient preference for, zolmitriptan orally disintegrating tablet. Curr Med Res Opin 21(Suppl 3):13–17.
   Google Scholar
• Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. 2004. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry 65:1372–1376.
   PubMed Web of Science ®Google Scholar
• Gift AG. 1989. Visual analogue scales: measurement of subjective phenomena. Nurs Res 38:286–288.
   PubMed Web of Science ®Google Scholar
• Guy W. 1976. Clinical Global Impressions ECDEU Assessment manual for psychopharmacology. Revised (DHEW Publ. No. ADM 76–338). Rockville, MD: National Institute of Mental Health/Bethesda, MD: US Department of Health Education, and Welfare. 217–222.
   Google Scholar
• Heres S, Schmitz FS, Leucht S, Pajonk FG. 2007. The attitude of patients towards antipsychotic depot treatment. Int Clin Psychopharmacol 22:275–282.
   PubMed Web of Science ®Google Scholar
• Hofer A, Kemmler G, Eder U, Honeder M, Hummer M, Fleischhacker WW. 2002. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia. J Clin Psychiatry 63:49–53.
   PubMed Web of Science ®Google Scholar
• Hogan TP, Awad AG, Eastwood R. 1983. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13:177–183.
   PubMed Web of Science ®Google Scholar
• Howard L, Thornicroft G. 2006. Patient preference randomised controlled trials in mental health research. Br J Psychiatry 188:303–304.
   PubMed Web of Science ®Google Scholar
• Jahng KH, Martin LR, Golin CE, DiMatteo MR. 2005. Preferences for medical collaboration: patient-physician congruence and patient outcomes. Patient Educ Couns 57:308–314.
   PubMed Web of Science ®Google Scholar
• Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IPM, . 2008. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371:1085–1097.
   PubMed Web of Science ®Google Scholar
• Karagianis J, Hoffmann VP, Arranz B, Treuer T, Maguire GA, de Haan L, . 2008. Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain. Hum Psychopharmacol 23:275–281.
   PubMedGoogle Scholar
• Kassirer JP. 1994. Incorporating patients’ preferences into medical decisions. New Engl J Med 330:1895–1896.
   PubMed Web of Science ®Google Scholar
• Kinon BJ, Hill AL, Liu H, Kollack-Walker S. 2003. Olanzapine orally disintegrating tablets in the treatment of acutely ill, non-compliant patients with schizophrenia. Int J Neuropsychopharmacol 6:97–102.
   PubMed Web of Science ®Google Scholar
• Leucht S, Komossa K, Rummel-Kluge C, Corves C, Hunger H, Schmid F, . 2009. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry 2:152–163.
   Google Scholar
• Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, . 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl J Med 353:1209–1223.
   PubMed Web of Science ®Google Scholar
• McKay JR, Alterman AI, McLellan T, Snider EC, O'Brien CP. 1995. Effect of random versus nonrandom assignment in a comparison of inpatient and day hospital rehabilitation for male alcoholics. J Consult Clin Psychol 63:70–78.
   PubMed Web of Science ®Google Scholar
• Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S, Lieberman JA. 2008. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophr Bull 35:336–346.
   PubMedGoogle Scholar
• Müller MJ. 2006. Attitudes toward different formulations of psychotropic drugs: the view of patients and healthcare providers. Am J Drug Delivery 4(1):33–41.
   Google Scholar
• Nausieda PA, Pfeiffer RF, Tagliati M, Kastenholz KV, DeRoche C, Slevin JT. 2005. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease. Clin Ther 27:58–63.
   PubMed Web of Science ®Google Scholar
• Novick D, Haro JM, Suarez D, Lambert M, Lépine JP, Naber D. 2007. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study. Psychopharmacology 191:1015–1022.
   PubMedGoogle Scholar
• Pascual JC, Pérez V, Martín JLR, Safont G, Puigdemont D, Álvarez E. 2007. Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study. Actas Esp Psiquiatr 35:47–51.
   PubMedGoogle Scholar
• Patel MX, De Zoysa N, Bernadt M, David A. 2009. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing. J Psychopharmacol 23:789–796.
   PubMed Web of Science ®Google Scholar
• Preference Collaborative Review Group. 2008. Patients’ preferences within randomised trials: systematic review and patient level meta-analyses. Br Med J 337:a1864
   Google Scholar
• EMEA Zyprexa Product Information. 28/07/2008 Zyprexa-H-C-115-II-92 http://www.emea.europa.eu/humandocs/PDFs/EPAR/Zyprexa/H-115-PI-en.pdf [July 3, 2009].
   Google Scholar
• Roger A, Fortea J, Mora S, Artés M. 2008. Ebastine fast-dissolving tablets versus regular tablets: acceptability and preference in patients with allergic rhinitis. Expert Rev Clin Pharmacol 1:381–389.
   PubMedGoogle Scholar
• San L, Casillas M, Ciudad A, Gilaberte I. 2008. Olanzapine orally disintegrating tablet: a review of efficacy and compliance CNS. Neurosci Ther 14:203–214.
   PubMed Web of Science ®Google Scholar
• Senn S. 1993. Cross-over trials in clinical research. New York: John Wiley & Sons. 104–109.
   Google Scholar
• Slevin JT, Ryan M. 2006. Orally disintegrating carbidopa/levodopa. Future Neurol 1:139–147.
   Google Scholar
• Steinberg SM, Venuto RC, Kuruvila CK, Taylor DO, Anil Kumar MS, Groothuis JR, . 2003. Randomized, open-label preference study of two cyclosporine capsule formulations (usp modified) in stable solid-organ transplant recipients. Clin Ther 25:2037–2052.
   PubMedGoogle Scholar
• Street RL Jr. 2007. Aiding medical decision making: a communication perspective. Med Decis Making 27:550–553.
   PubMedGoogle Scholar
• Swartz MS, Swanson JW, Wagner RH, Burns BJ, Hiday VA. 2001. Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness. J Nerv Ment Dis 189:583–592.
   PubMed Web of Science ®Google Scholar
• Voss TC, Klapper JA. 2002. Patient preference for orally dissolving rizatriptan or zolmitriptan: a comparative, open-label, randomized, crossover trial in triptan experienced patients. Headache. 42:401–447.
   Google Scholar
• Ward E, King M, Lloyd M, Bower P, Sibbald B, Farrelly S, . 2000. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: clinical effectiveness. Br Med J 321:1383–1388.
   PubMed Web of Science ®Google Scholar